EXPLAINED: How India's First Homegrown mRNA Vaccine Can Provide Helping Hand Against Omicron

The country's first messenger RNA, or mRNA, vaccine, is prepping for launch with the Pune-based Gennova Biopharmaceuticals on course with its human trials, reports say, adding that a variant-specific version is also in the works to tackle the Omicron variant. Amid the pandemic, mRNA vaccines have reported a strong ability to impart protection against the novel coronavirus and two notable candidates – created by Pfizer-BioNTech and Moderna – are the mainstays of the vaccination drive of several advanced nations.

Leave a Reply